Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | PPARG | P37231 | 2/20 | 0.59 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | GRM2 | Q14416 | 7/20 | 0.43 |
| ▸ | PRKCA | P17252 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL111041 | 1.00 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL7059195 | 1.00 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL333202 | 1.00 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL113498 | 1.00 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL3661965 | 1.00 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL7059128 | 1.00 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL2077607 | 1.00 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL8210280 | 1.00 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL17627672 | 1.00 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL113200 | 1.00 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120022317-A | Lucid ganoderma fermented green tea and preparation method and application thereof | 湖南农业大学 | 2025-05-23 | — | — | CN | claimed |
| EP-2846635-B1 | CONTROL AND REPELLENCY OF BED BUGS | BEDOUKIAN RES INC (US) | 2023-08-30 | — | — | EP | claimed |
| WO-2022035645-A1 | SYNERGISTIC FORMULATIONS FOR CONTROL AND REPELLENCY OF BITING ARTHROPODS | BEDOUKIAN RESEARCH, INC. (US) | 2022-02-17 | — | — | WO | claimed |
| US-20200367497-A1 | SYNERGISTIC FORMULATIONS FOR CONTROL AND REPELLENCY OF BITING ARTHROPODS | BEDOUKIAN RESEARCH, INC. (US) | 2020-11-26 | — | — | US | claimed |
| US-10703705-B2 | Control and repellency of bed bugs | BEDOUKIAN RESEARCH, INC. (US) | 2020-07-07 | — | — | US | claimed |
| WO-2013079187-A9 | TASTE-MASKING COMPOSITIONS, SWEETENER COMPOSITIONS AND CONSUMABLE PRODUCT COMPOSITIONS CONTAINING THE SAME | NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) | 2016-04-14 | — | — | WO | claimed |
| US-20150152038-A1 | CONTROL AND REPELLENCY OF BED BUGS | BEDOUKIAN RESEARCH, INC. | 2015-06-04 | — | — | US | claimed |
| EP-2846635-A1 | CONTROL AND REPELLENCY OF BED BUGS | Bedoukian Research, Inc. (US) | 2015-03-18 | — | — | EP | claimed |
| EP-2785199-A2 | TASTE-MASKING COMPOSITIONS, SWEETENER COMPOSITIONS AND CONSUMABLE PRODUCT COMPOSITIONS CONTAINING THE SAME | Nutrinova Nutrition Specialties & Food Ingredients GmbH (DE) | 2014-10-08 | — | — | EP | claimed |
| WO-2013165478-A1 | CONTROL AND REPELLENCY OF BED BUGS | BEDOUKIAN RESEARCH, INC. (US) | 2013-11-07 | — | — | WO | claimed |
| WO-2013079187-A2 | TASTE-MASKING COMPOSITIONS, SWEETENER COMPOSITIONS AND CONSUMABLE PRODUCT COMPOSITIONS CONTAINING THE SAME | NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) | 2013-06-06 | — | — | WO | claimed |
| US-20130136839-A1 | Taste-Masking Compositions, Sweetener Compositions and Consumable Product Compositions Containing the Same | NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) | 2013-05-30 | — | — | US | claimed |
| US-20130136836-A1 | Taste-Masking Compositions, Sweetener Compositions and Consumable Product Compositions Containing the Same | NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) | 2013-05-30 | — | — | US | claimed |
| US-6639089-B2 | Therapy, side effect reduction | SODA AROMATIC CO., LTD. | 2003-10-28 | — | — | US | claimed |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) | 2003-03-20 | — | — | US | claimed |
| CN-1394139-A | Anticancer agents | SODA AROMATIC (JP) | 2003-01-29 | — | — | CN | claimed |
| EP-1249236-A1 | ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS | SODA AROMATIC COMPANY, LIMITED (JP) | 2002-10-16 | — | — | EP | claimed |
| CN-120022317-A | Lucid ganoderma fermented green tea and preparation method and application thereof | 湖南农业大学 | 2025-05-23 | — | — | CN | disclosed |
| US-4246182-A | Process for the preparation of omega-hydroxy fatty acids from omega-hydroxy (or acyloxy)-alkyl-γ-butyrolactones | SODA KORYO KABUSHIKI KAISHA (JP) | 1981-01-20 | — | — | US | disclosed |
| US-4244873-A | Omega-hydroxy or acyloxy-alkyl-γ-butyrolactones | SODA KORYO KABUSHIKI KAISHA (JP) | 1981-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10703705-B2 | Control and repellency of bed bugs | NR1H3, OR10J3, NR1H2 | CYP1A2 573/4885PPARG 1674/4885EPHX1 659/4885 |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | ALOX5, ELOVL5, ELOVL3 | CYP1A2 640/4885PPARG 192/4885EPHX1 48/4885 |
| US-20150152038-A1 | CONTROL AND REPELLENCY OF BED BUGS | NR1H3, OR10J3, NR1H2 | CYP1A2 573/4885PPARG 1674/4885EPHX1 659/4885 |
| US-20200367497-A1 | SYNERGISTIC FORMULATIONS FOR CONTROL AND REPELLENCY OF BITING ARTHROPODS | DDT, PNMT, ACMSD | CYP1A2 1606/4885PPARG 4057/4885EPHX1 1573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.